EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer

Sofie Traynor, Mie K Jakobsen, Tina M Green, Hana Komic, Yaseelan Palarasah, Christina B Pedersen, Henrik J Ditzel iD, Fredrik B Thoren, Per Guldberg, Morten F Gjerstorff iD

Journal for ImmunoTherapy of Cancer · 2024-06 · 12 (6) · e008759

DOI: 10.1136/jitc-2023-008759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 17.06.2024. Verfasst von Sofie Traynor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Melanoma, Lung Neoplasms, Antigens, Neoplasm, Single-Cell Analysis. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agnes and Poul Friis Foundation, Pink tribute, Frimodt-Heineke Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer/testis antigens (CTAs) are widely expressed in melanoma and lung cancer, emerging as promising targets for vaccination strategies and T-cell-based therapies in these malignancies. Despite recognizing the essential impact of intratumoral heterogeneity on clinical responses to immunotherapy, our understanding of intratumoral heterogeneity in CTA expression has remained limited. We employed single-cell mRNA sequencing to delineate the CTA expression profiles of cancer cells in clinically derived melanoma and lung cancer samples. Our findings reveal a high degree of intratumoral transcriptional heterogeneity in CTA expression. In melanoma, every cell expressed at least one CTA. However, most individual CTAs, including the widely used therapeutic targets NY-ESO-1 and MAGE, were confined to subpopulations of cells and were uncoordinated in their expression, resulting in mosaics of cancer cells with diverse CTA profiles. Coordinated expression was observed, however, mainly among highly structurally and evolutionarily related CTA genes. Importantly, a minor subset of CTAs, including PRAME and several members of the GAGE and MAGE-A families, were homogenously expressed in melanomas, highlighting their potential as therapeutic targets. Extensive heterogeneity in CTA expression was also observed in lung cancer. However, the frequency of CTA-positive cancer cells was notably lower and homogenously expressed CTAs were only identified in one of five tumors in this cancer type. Our findings underscore the need for careful CTA target selection in immunotherapy development and clinical testing and offer a rational framework for identifying the most promising candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaLung NeoplasmsAntigens, NeoplasmSingle-Cell AnalysisHumansMaleGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Lung CancerSkin Cancer

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Department of Pathology, Odense University Hospital, Odense, Denmark.
  • TIMM Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Goteborg, Sweden.
  • Department of Medical Biochemistry and Cell Biology, University of Gothenburg, Goteborg, Sweden.
  • Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Danish Cancer Institute, Kobenhavn, Denmark.

ORCID-Profile: Henrik J Ditzel, Morten F Gjerstorff

Förderung

  • Agnes and Poul Friis Foundation
  • Pink tribute
  • Frimodt-Heineke Foundation
  • Danish Cancer Society
  • Dagmar Marshalls Foundation
  • Læge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat
  • The Region of Southern Denmark
  • Einar Willumsen Foundation

Zitieren

APA

Traynor, S., Jakobsen, M. K., Green, T. M., Komic, H., Palarasah, Y., Pedersen, C. B., Ditzel, H. J., Thoren, F. B., Guldberg, P., & Gjerstorff, M. F. (2024). Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for ImmunoTherapy of Cancer, 12(6), e008759. https://doi.org/10.1136/jitc-2023-008759

Vancouver

Traynor S, Jakobsen MK, Green TM, Komic H, Palarasah Y, Pedersen CB, et al. Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer. Journal for ImmunoTherapy of Cancer. 2024;12(6):e008759. doi:10.1136/jitc-2023-008759

BibTeX
@article{Traynor2024,
  author = {Traynor, Sofie and Jakobsen, Mie K and Green, Tina M and Komic, Hana and Palarasah, Yaseelan and Pedersen, Christina B and Ditzel, Henrik J and Thoren, Fredrik B and Guldberg, Per and Gjerstorff, Morten F},
  title = {Single-cell sequencing unveils extensive intratumoral heterogeneity of cancer/testis antigen expression in melanoma and lung cancer},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {e008759},
  doi = {10.1136/jitc-2023-008759}
}
Kostenlos starten →